I presented on OpenTox applications at the BIO-IT 2011 conference this week (Boston, 12 -14 April 2011) in the workshop session on Current Methods for Computational Toxicology and Chemogenomics. Presenting in this productive and interactive session:
•Josef Scheiber, Ph.D., Pharma Research & Early Development Informatics, F. Hoffmann-La Roche Ltd.
•Jeremy Jenkins, Ph.D., Senior Investigator I, Developmental & Molecular Pathways, Quantitative Biology, Novartis Institutes for BioMedical Research
•Christopher Southan, Ph.D., ChrisDS Consulting
•Luis Tari, Ph.D., Postdoc Research Fellow, Biomedical Informatics, F. Hoffmann-La Roche Ltd.
•Antony Williams, Ph.D., Vice President, Strategic Development, ChemSpider, Royal Society of Chemistry
•Yuriy Gankin, Ph.D., Co-Founder and Chief Scientific Officer, GGA Software Services
•Barry Hardy, Ph.D.,Director, Community of Practice & Research Activities and OpenTox Project Coordinator,
The conference showed the growing acceptance and indeed demand by industry for Open Source and Open Standards-oriented solutions which are increasingly providing both superior technical solutions and lower cost end user service-oriented business cases.
The OpenTox presentation includes developments on numerous end user applications (built upon OpenTox APIs and web services) including ToxCreate, ToxPredict, Bioclipse, Qedit, Ches-Mapper, and integration examples with other platforms and initiatives such as CDK, ToxML, and ToxCast. You can download a copy of the slides from: